Chris Farkas
Analyst · Morgan Stanley. Your line is now open
Thank you, Lynn, and good morning, everyone. I’ll begin with key drivers of our fourth quarter results by segment. Starting in Aerospace and Industrial, we experienced an 8% increase in sales driven by solid demand across all of our major markets. This included double-digit growth increases in general industrial, where we continue to benefit from strong order activity and also within aerospace defense, where we had higher revenues on various fighter jets. Within the segment’s commercial aerospace market, we experienced improved demand on narrow-body aircraft, which was partially offset by the wide-body delays due to the 787 certification. The segment’s adjusted operating income increased 20%, while adjusted operating margin increased 200 basis points to 19.5%. Our results reflect favorable absorption on strong sales and various pricing and operational excellence initiatives that mitigated supply chain headwinds across our business. In the Defense Electronics segment, sales increased 10%, reflecting strong demand for PacStar’s communication equipment in ground defense and higher revenues in Virginia class submarines in naval defense. Our results would have been even stronger, if not for the timing and delayed receipt of electronic components resulting from the continued challenges affecting global supply chains. In Aerospace Defense, while we had higher revenues on the F-35 program, revenue timing was once again a factor as we experienced a shift of approximately $20 million in sales out of 2021. The segment’s adjusted operating income increased 17%, while adjusted operating margin increased 160 basis points to 26.5%, reflecting favorable absorption on sales and improved mix based upon the push-out of lower margin system sales. Next, in Naval & Power segment, our results reflect the timing of sales of our naval nuclear propulsion equipment and reduced CAP1000 revenues as this program continues to wind down. Conversely, we experienced higher valve sales due to continued strong demand in the process markets and modest growth in the nuclear aftermarket supporting existing operating reactors. This segment’s adjusted operating income decreased 16%, while adjusted operating margin was 19.3%, reflecting unfavorable absorption on lower sales as well as investments in operational excellence to help reposition the business for lower CAP1000 program revenue. To sum up the fourth quarter results, overall, both sales and adjusted operating income increased 2%, with a strong but flat year-over-year operating margin of nearly 20%. Turning to our full year 2022 guidance, I’ll begin on Slide 5 with our end-market sales outlook where we expect total Curtiss-Wright organic sales growth of 3% to 5%. This growth includes contributions from all of our end markets, driven by 2% to 4% growth in A&D and 4% to 6% growth in Commercial. For full year 2022, we expect our A&D markets will represent two-thirds of the total company sales prior to the acquisition of Safran. In aerospace defense, we expect higher sales for embedded computing equipment on various C5ISR programs within our Defense Electronics segment, however, those gains will be mainly offset by the timing of actuation equipment sales within our A&I segment, principally on the F-35 program. In Ground Defense, we expect higher revenues for tactical battlefield communication systems to be slightly offset by lower domestic ground vehicle sales. And next, in Naval Defense, higher revenues driven by the strong ramp-up on the CVN-81 aircraft carrier and increased production on the first Columbia class submarine will be partially offset by the expected ramp-down in production on the CVN-80, which reached peak revenues for Curtiss-Wright in 2021. Please note that our guidance within those defense end markets not only reflects the continued impacts on our supply chain principally for small electronics, but also the delayed signing of the DoD budget. We and industry are now faced with an extended continuing resolution to begin 2022, halting new program starts and the availability of additional funding until the appropriations bill is signed into law. We continue to monitor the current environment and while it’s difficult to estimate the immediate impact on our ‘22 performance, we remain confident in our long-term position as a critical supplier to the defense industry. Rounding out our A&D markets and turning to commercial aerospace, which we expect to be our fastest-growing end market in 2022 with 9% to 11% sales growth. This outlook is driven by strong growth in OEM sales on narrow-body aircraft, including the 737 and A320 programs as well as a modest growth in aftermarket. Next, turning to our commercial markets, in Power & Process, we are expecting 1% to 3% growth overall. However, this outlook includes a revenue headwind from the CAP1000 program of approximately $20 million as this program winds down. Looking beyond that impact, we expect mid-single-digit growth in both the nuclear aftermarket and process markets as they continue to rebound back to 2019 levels. In the nuclear aftermarket, our outlook principally reflects solid demand for ongoing maintenance and subsequent license renewals to extend the life of the nuclear power generation fleet. In the process market, we continue to see a strong rebound in MRO activity for our valve businesses, driven by higher demand as oil and gas prices continue to climb. And lastly, in the general industrial market, we anticipate building upon the strong 2021 performance with another solid outlook of 6% to 8% growth in 2022, which, once again, will be driven by orders for industrial vehicle products. Continuing with our full year outlook by segment on Slide 6, I will begin in the Aerospace and Industrial segment, which we expect to be our fastest-growing segment in 2022 with 4% to 6% sales growth. Our outlook for this segment is driven by strong growth in both commercial aerospace and general industrial, partially offset by lower sales in aerospace defense. We expect adjusted operating income growth of 9% to 12% and adjusted operating margin expansion of 70 to 90 basis points to a range of 16.2% to 16.4%, reflecting higher sales and the benefits of our prior year restructuring initiatives. In addition, we expect that the continued recovery in our commercial industrial markets, along with our strong backlog, will not only benefit our 2022 performance but also future years’ growth in sales and profitability in the A&I segment. Next, in the Defense Electronics segment, we expect sales to grow 2% to 4%, led by modest growth in aerospace and ground defense. Supply chain remains a dynamic issue for Curtiss-Wright and particularly within the segment where we continue to be faced with rapid changes in the availability of electronic components. While our sales and profitability for our Defense Electronics businesses are typically weighted to the second half, we expect a more pronounced shift in sales to the back half of 2022, driven by the supply chain. Operating income is projected to be flat to up 3%, while operating margin is projected to decline 40 to 60 basis points. However, it’s worth noting that this outlook includes a year-over-year increase in strategic R&D investments of $7 million impacting our full year results by approximately 90 basis points. Lastly, in the Naval & Power segment, we expect sales to grow 2% to 3%, driven by solid growth in naval defense as well as mid-single-digit growth in both the nuclear aftermarket and process market. Similar to the earlier guidance within the Power and Process market, the Naval & Power segment outlook includes the wind down on profitable CAP1000 program. Operating income is projected to grow 1% to 4% with an essentially flat but strong operating margin ranging from 18.1% to 18.3%. Excluding the CAP1000 revenue headwind of approximately $20 million, our results would reflect mid-single-digit sales growth and a solid incremental margin expansion, reflecting the benefit of our ongoing operational excellence initiatives, which we have tailored to effectively reposition the business. So in summary, we expect total Curtiss-Wright adjusted operating income to grow 3% to 6% overall on a 3% to 5% increase in sales. Operating margin is expected to improve 10 to 30 basis points ranging from 17.1% to 17.3%, including an $8 million increase in R&D investments in the aforementioned CAP1000 headwinds. Continuing with our financial outlook on Slide 7, we expect full year 2022 adjusted diluted EPS to range from $8.05 to $8.25, up 10% to 12%, reflecting both the contributions from our growth in operating income as well as lower share count stemming from our record $350 million share repurchase activity in 2021 and our minimum commitment of $50 million in 2022. It’s also important to note that this EPS growth includes the aforementioned increase in R&D, which equates to $0.16 per share. To aid in your quarterly modeling, we expect first quarter 2022 adjusted diluted EPS to be below the first quarter of 2021 results and are currently estimating approximately $1.20 per share based upon continued supply chain headwinds and significant changes in product mix. We then expect to follow a similar cadence to prior years with the first quarter being our lightest, followed by sequential quarterly improvement in the fourth quarter being our strongest again with a higher-than-normal weighting to the second half. Lastly, turning to our free cash flow guidance, cash flow from operations reflects solid growth of 2% to 10% while capital expenditures are expected to increase $10 million to $20 million as we look to invest to support future organic growth. As a result, we are projecting full year adjusted free cash flow guidance of $345 million to $365 million. Finally, we expect to exceed our long-term free cash flow conversion target of 110% again in 2022, which would also represent our tenth consecutive year exceeding 100% conversion. Now I’d like to turn the call back over to Lynn to continue with our prepared remarks. Lynn?